OKYO Pharma Ltd

OKYO

As of the close on Sep 25, 2026

Price

$1.38

Market cap

—

Figures are per ordinary share in the filer's currency; the US price is per depositary share

P/E (diluted TTM)

—

The last four quarters are not all on file

EPS (TTM)

—

The last four quarters are not all on file

Dividend yield

—

Figures are per ordinary share in the filer's currency; the US price is per depositary share

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How OKYO Pharma Ltd Makes Money

No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Mar 31, 2026. The latest insider filing shown is dated Jun 10, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Purchases & sales (open market or private)

		Security	Code		Price	Filing
2023-09-15	BRANCACCIO JOHN P · Director	Ordinary Shares	P — Open market or private purchase	+16,670	1.50	SEC filing
2022-05-19	CERRONE GABRIELE M · Executive Chairman	Ordinary Shares	P — Open market or private purchase	+5,800,000	0.08	SEC filing
2022-05-19	JACOB GARY S · Chief Executive Officer	American Depositary Shares	P — Open market or private purchase	+12,500	4.00	SEC filing
2022-05-19	CERRONE GABRIELE M · Non-Executive Chairman	American Depositary Shares	P — Open market or private purchase	+37,500	4.00	SEC filing
2022-05-17	CERRONE GABRIELE M · Non-Executive Chairman	Ordinary Shares	P — Open market or private purchase	+1,625,000	0.06	SEC filing
2022-05-17 (amended)	CERRONE GABRIELE M · Non-Executive Chairman	American Depositary Shares	P — Open market or private purchase	+25,000	3.87	SEC filing

Showing 6 of 6 rows

Grants, exercises, tax & gifts

		Security	Code		Filing
2026-06-08	Shah Keeren Rameshchandra · Chief Financial Officer	Option	A — Grant, award, or other acquisition	+40,000	SEC filing
2026-06-08	Simon Willy Jules · Director	Option	A — Grant, award, or other acquisition	+6,500	SEC filing
2026-06-08	Denoyer Bernard · Director	Option	A — Grant, award, or other acquisition	+3,500	SEC filing
2026-06-08	CERRONE GABRIELE M · Director, 10% owner	COMMON STOCK	A — Grant, award, or other acquisition	+300,000	SEC filing
2026-06-08	BRANCACCIO JOHN P · Director	Option	A — Grant, award, or other acquisition	+6,500	SEC filing

Showing 5 of 5 rows

Other activity

		Security	Code		Filing
2023-10-27	CERRONE GABRIELE M · Executive Chairman	Ordinary Shares	J — Other acquisition or disposition	+70,071	SEC filing
2023-10-23	CERRONE GABRIELE M · Executive Chairman	Ordinary Shares	J — Other acquisition or disposition	+499,468	SEC filing

Showing 2 of 2 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.